NCT00654238
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +20 more
- Locations
-
- University of Pennsylvania - Abramson Comprehensive Cancer Center Philadelphia, Pennsylvania, United States
Clinical trial condition
Thyroid Carcinoma, Anaplastic
Explore clinical trials studying Thyroid Carcinoma, Anaplastic. Study availability and eligibility vary by location and protocol.
57 public trials
11 recruiting studies
Thyroid Carcinoma, Anaplastic trial results
NCT00095836
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +20 more
- Locations
-
- Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT01240590
- Conditions
- Anaplastic Thyroid Cancer, Carcinoma, Neoplasms, +4 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
NCT01164176
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +20 more
- Locations
-
- Hallym University Sacred Heart Hospital Anyang, Gyeonggi-do, South Korea
- Yeungnam University Medical Center Daegu, South Korea
- National Cancer Center - Korea Goyang, South Korea
- Kosin Medical Center Gospel Hospital Pusan, South Korea
NCT00002608
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +71 more
- Locations
-
- Ottawa Regional Cancer Centre at Ottawa Hospital - General Campus Ottawa, Ontario, Canada
Completed
Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Thyroid Cancer
NCT00004089
- Conditions
- Carcinoma, Head and Neck Cancer, Head and Neck Neoplasms, +5 more
- Locations
-
- Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States
- University of Illinois at Chicago Chicago, Illinois, United States
- University of Chicago Cancer Research Center Chicago, Illinois, United States
NCT00019331
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +88 more
- Locations
-
- Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States
Completed
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu
NCT00004074
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +257 more
- Locations
-
- Ohio State University Medical Center Columbus, Ohio, United States
NCT00005842
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +135 more
- Locations
-
- Brooke Army Medical Center Fort Sam Houston, Texas, United States
- Institute for Drug Development San Antonio, Texas, United States
NCT00068497
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +132 more
- Locations
-
- Southwest Oncology Group San Antonio, Texas, United States